ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
Hemasphere
.
2023 Sep 19;7(10):e967.
doi: 10.1097/HS9.0000000000000967.
eCollection 2023 Oct.
Authors
Inge van Outersterp
1
,
Vincent H J van der Velden
2
,
Patricia G Hoogeveen
2
,
Goda E Vaitkevičienė
3
4
,
Edwin Sonneveld
1
5
,
Gijs van Haaften
6
,
Roland P Kuiper
1
6
,
Udo Zur Stadt
7
,
Gabriele Escherich
7
,
Judith M Boer
1
,
Monique L den Boer
1
8
Affiliations
1
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
2
Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
3
Faculty of Medicine, Vilnius University, Lithuania.
4
Center for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Lithuania.
5
Dutch Childhood Oncology Group, Utrecht, The Netherlands.
6
Department of Genetics, University Medical Center Utrecht, The Netherlands.
7
Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany.
8
Department of Pediatric Oncology and Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
PMID:
37736661
PMCID:
PMC10511034
DOI:
10.1097/HS9.0000000000000967
No abstract available